Follow
Ruiqing Ni
Ruiqing Ni
ETH Zurich & University of Zurich
Verified email at biomed.ee.ethz.ch
Title
Cited by
Cited by
Year
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies
M Ono, N Sahara, K Kumata, B Ji, R Ni, S Koga, DW Dickson, ...
Brain 140 (3), 764-780, 2017
2122017
Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study
E Rodriguez-Vieitez, R Ni, B Gulyás, M Tóth, J Häggkvist, C Halldin, ...
European journal of nuclear medicine and molecular imaging 42, 1119-1132, 2015
1362015
Amyloid tracers detect multiple binding sites in Alzheimer’s disease brain tissue
R Ni, PG Gillberg, A Bergfors, A Marutle, A Nordberg
Brain 136 (7), 2217-2227, 2013
1282013
Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain
R Ni, A Marutle, A Nordberg
Journal of Alzheimer's Disease 33 (3), 841-851, 2013
1122013
PET imaging of Neuroinflammation in Alzheimer’s disease
R Zhou, BIN JI, Y Kong, L Qin, W Ren, Y Guan, R Ni
Frontiers in Immunology, 3750, 2021
862021
3H-Deprenyl and 3H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain
A Marutle, PG Gillberg, A Bergfors, W Yu, R Ni, I Nennesmo, L Voytenko, ...
Journal of neuroinflammation 10, 1-15, 2013
772013
Comparative in vitro and in vivo quantifications of pathologic tau deposits and their association with neurodegeneration in tauopathy mouse models
R Ni, B Ji, M Ono, N Sahara, MR Zhang, I Aoki, A Nordberg, T Suhara, ...
Journal of Nuclear Medicine 59 (6), 960-966, 2018
642018
Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients
IL Choo, R Ni, M Schöll, A Wall, O Almkvist, A Nordberg
Journal of Alzheimer's Disease 33 (4), 929-939, 2013
622013
In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510
A Ishikawa, T Masaki, M Jun, M Takeharu, S Masafumi, T Hiroyuki, ...
Journal of Alzheimer's disease 61 (3), 1037-1052, 2018
592018
Multi-scale optoacoustic molecular imaging of brain diseases
D Razansky, J Klohs, R Ni
European journal of nuclear medicine and molecular imaging 48 (13), 4152-4170, 2021
572021
Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer’s disease
R Ni, M Rudin, J Klohs
Photoacoustics 10, 38-47, 2018
532018
Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system
R Ni, L Mu, S Ametamey
Acta Pharmacologica Sinica 40 (3), 351-357, 2019
412019
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice
R Ni, Z Chen, XL Deán-Ben, FF Voigt, D Kirschenbaum, G Shi, A Villois, ...
Nature Biomedical Engineering, 1-14, 2022
392022
fMRI reveals mitigation of cerebrovascular dysfunction by bradykinin receptors 1 and 2 inhibitor noscapine in a mouse model of cerebral amyloidosis
R Ni, DR Kindler, R Waag, M Rouault, P Ravikumar, R Nitsch, M Rudin, ...
Frontiers in aging neuroscience 11, 27, 2019
352019
In vitro characterization of the regional binding distribution of amyloid PET tracer florbetaben and the glia tracers deprenyl and PK11195 in autopsy Alzheimer’s brain tissue
R Ni, J Röjdner, L Voytenko, T Dyrks, A Thiele, A Marutle, A Nordberg
Journal of Alzheimer's Disease 80 (4), 1723-1737, 2021
342021
Automated registration of magnetic resonance imaging and optoacoustic tomography data for experimental studies
W Ren, H Skulason, F Schlegel, M Rudin, J Klohs, R Ni
Neurophotonics 6 (2), 025001, 2019
332019
Noninvasive detection of acute cerebral hypoxia and subsequent matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral-optoacoustic-tomography
R Ni, M Vaas, W Ren, J Klohs
Neurophotonics 5 (1), 015005, 2018
332018
Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography
P Vagenknecht, A Luzgin, M Ono, B Ji, M Higuchi, D Noain, CA Maschio, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-16, 2022
322022
Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease
R Ni, PG Gillberg, N Bogdanovic, M Viitanen, L Myllykangas, I Nennesmo, ...
Alzheimer's & dementia 13 (4), 419-430, 2017
312017
In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice
Ruiqing Ni, Alessia Villois, Xose LuisDean-Ben, Zhenyue Chen, Markus Vaas ...
Photoacoustics, 2021
302021
The system can't perform the operation now. Try again later.
Articles 1–20